MetaADEDB 2.0 @ LMMD
Travoprost
(MKPLKVHSHYCHOC-AHTXBMBWSA-N)
Structure
SMILES
CC(OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O)C
Type(s)
Approved
ATC code(s)
S01EE04
Molecular Formula:
C26H35F3O6
Molecular Weight:
500.548
Log P:
4.4274
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
3
TPSA:
96.22
CAS Number(s):
157283-68-6
Synonym(s)
1.
Travoprost
2.
(((1R)-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester
3.
AL-6221
4.
AL6221
5.
Travatan
6.
Travatan Z
7.
AL 6221
8.
Z, Travatan
External Link(s)
MeSHD000069557
PubChem Compound5282226
BindingDB50248302
ChEBI746859
CHEMBLCHEMBL1200799
DrugBankDB00287
DrugCentral2716
IUPHAR/BPS Guide to PHARMACOLOGY7102
KEGGdr:D01964
Therapeutic Target DatabaseD09CZA
ZINC4474682
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Eye irritationFAERS: 213
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
2Eye painFAERS: 129
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
3Drug ineffectiveFAERS: 122
Canada Vigilance: 7
Canada Vigilance
US FAERS
4Visual ImpairmentFAERS: 60
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
5GlaucomaFAERS: 5918837686CTD
OFFSIDES
US FAERS
6No adverse eventFAERS: 44US FAERS
7Product quality issueFAERS: 34OFFSIDES
US FAERS
8HeadacheFAERS: 31
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
9Product dropper issueFAERS: 30US FAERS
10BlindnessFAERS: 28US FAERS
11CataractFAERS: 28OFFSIDES
SIDER
US FAERS
12Growth of eyelashesFAERS: 28
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
13PhotophobiaFAERS: 26SIDER
US FAERS
14Foreign body sensation in eyesFAERS: 24OFFSIDES
SIDER
US FAERS
15HypersensitivityFAERS: 24SIDER
US FAERS
16MalaiseFAERS: 24
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
17DizzinessFAERS: 22
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
18Expired product administeredFAERS: 22US FAERS
19Ocular discomfortFAERS: 21
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
20ErythemaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
21Diabetes MellitusFAERS: 16US FAERS
22NasopharyngitisFAERS: 16US FAERS
23Accidental exposure to productFAERS: 15US FAERS
24Feeling abnormalFAERS: 15OFFSIDES
SIDER
US FAERS
25PruritusFAERS: 15SIDER
US FAERS
26FatigueFAERS: 14
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
27Product use issueFAERS: 14US FAERS
28Therapy partial responderFAERS: 14US FAERS
29Dark circles under eyesFAERS: 13SIDER
US FAERS
30Incorrect dose administeredFAERS: 13US FAERS
31Cerebrovascular accidentFAERS: 12US FAERS
32Product packaging quantity issueFAERS: 12US FAERS
33AnxietyFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
34Chest PainFAERS: 11
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
35Intraocular pressure fluctuationFAERS: 11US FAERS
36PainFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
37PalpitationsFAERS: 11SIDER
US FAERS
38UveitisFAERS: 1119403113CTD
SIDER
US FAERS
39DeafnessFAERS: 10OFFSIDES
US FAERS
40DiplopiaFAERS: 10OFFSIDES
US FAERS
41Myocardial InfarctionFAERS: 10US FAERS
42Retinal DetachmentFAERS: 10SIDER
US FAERS
43AsthmaFAERS: 9SIDER
US FAERS
44Memory impairmentFAERS: 9US FAERS
45Throat irritationFAERS: 9SIDER
US FAERS
46TinnitusFAERS: 9OFFSIDES
SIDER
US FAERS
47TremorFAERS: 9US FAERS
48ArthralgiaFAERS: 8SIDER
US FAERS
49AstheniaFAERS: 8SIDER
US FAERS
50Back PainFAERS: 8SIDER
US FAERS
51Chest discomfortFAERS: 8US FAERS
52ConjunctivitisFAERS: 8SIDER
US FAERS
53Detachment of retinal pigment epitheliumFAERS: 8OFFSIDES
US FAERS
54Eye allergyFAERS: 8SIDER
US FAERS
55InfluenzaFAERS: 8SIDER
US FAERS
56IritisFAERS: 8OFFSIDES
SIDER
US FAERS
57NauseaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
58Product container issueFAERS: 8US FAERS
59ArthritisFAERS: 7SIDER
US FAERS
60BlepharitisFAERS: 7OFFSIDES
SIDER
US FAERS
61DysphoniaFAERS: 7OFFSIDES
SIDER
US FAERS
62Eye inflammationFAERS: 7OFFSIDES
US FAERS
63Product administration errorFAERS: 7US FAERS
64Abdominal discomfortFAERS: 6
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
65Drug exposure during pregnancyFAERS: 6US FAERS
66Iris hyperpigmentationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
67Periorbital fat atrophyFAERS: 6US FAERS
68Weight decreasedFAERS: 6US FAERS
69Atrial FibrillationFAERS: 5US FAERS
70Choroidal DetachmentFAERS: 5US FAERS
71Drug administration errorFAERS: 5US FAERS
72DysgeusiaFAERS: 5OFFSIDES
SIDER
US FAERS
73Eyelids pruritusFAERS: 5OFFSIDES
SIDER
US FAERS
74General physical health deteriorationFAERS: 5US FAERS
75Intraocular pressure test abnormalFAERS: 5US FAERS
76Liquid product physical issueFAERS: 5US FAERS
77Macular degenerationFAERS: 5SIDER
US FAERS
78NervousnessFAERS: 5US FAERS
79Ocular HypertensionFAERS: 519403113CTD
OFFSIDES
US FAERS
80Oropharyngeal painFAERS: 5SIDER
US FAERS
81Product packaging issueFAERS: 5US FAERS
82Product storage errorFAERS: 5US FAERS
83SinusitisFAERS: 5OFFSIDES
SIDER
US FAERS
84TachycardiaFAERS: 5SIDER
US FAERS
85AgeusiaFAERS: 4OFFSIDES
US FAERS
86AnosmiaFAERS: 4US FAERS
87BradycardiaFAERS: 4OFFSIDES
SIDER
US FAERS
88DementiaFAERS: 4US FAERS
89Drug dispensing errorFAERS: 4US FAERS
90EntropionFAERS: 4OFFSIDES
US FAERS
91Eyelash thickeningFAERS: 4SIDER
US FAERS
92Eyelid margin crustingFAERS: 4SIDER
US FAERS
93HypotensionFAERS: 4SIDER
US FAERS
94Pharmaceutical product complaintFAERS: 4US FAERS
95PneumoniaFAERS: 4US FAERS
96Product label issueFAERS: 4US FAERS
97SciaticaFAERS: 4US FAERS
98Skin irritationFAERS: 4US FAERS
99SomnolenceFAERS: 4US FAERS
100Superficial injury of eyeFAERS: 4US FAERS
101AlopeciaFAERS: 3US FAERS
102Angina PectorisFAERS: 3SIDER
US FAERS
103Anterior chamber inflammationFAERS: 3OFFSIDES
SIDER
US FAERS
104AsthenopiaFAERS: 3OFFSIDES
SIDER
US FAERS
105BlepharospasmFAERS: 3US FAERS
106Burning sensationFAERS: 3US FAERS
107Cardiac ArrestFAERS: 3US FAERS
108ChokingFAERS: 3US FAERS
109Coronary Artery DiseaseFAERS: 3US FAERS
110DysgraphiaFAERS: 3OFFSIDES
US FAERS
111Ear discomfortFAERS: 3US FAERS
112EpistaxisFAERS: 3OFFSIDES
US FAERS
113Eye InfectionFAERS: 3OFFSIDES
US FAERS
114Product use complaintFAERS: 3US FAERS
115Punctate keratitisFAERS: 3OFFSIDES
SIDER
US FAERS
116Sinus TachycardiaFAERS: 3US FAERS
117Tension HeadacheFAERS: 3US FAERS
118Therapeutic response unexpectedFAERS: 3US FAERS
119TrichiasisFAERS: 3OFFSIDES
US FAERS
120UrticariaFAERS: 3US FAERS
121VertigoFAERS: 3SIDER
US FAERS
122Wrong drug administeredFAERS: 3US FAERS
123Anaphylactic shockFAERS: 2US FAERS
124AphasiaFAERS: 2US FAERS
125ArthropathyFAERS: 2US FAERS
126Bladder prolapseFAERS: 2US FAERS
127Blood urine presentFAERS: 2US FAERS
128Cataract operationFAERS: 2OFFSIDES
US FAERS
129Chemical eye injuryFAERS: 2US FAERS
130ChillsFAERS: 2US FAERS
131ChromatopsiaFAERS: 2US FAERS
132Concomitant disease aggravatedFAERS: 2US FAERS
133Device damageFAERS: 2US FAERS
134DiscomfortFAERS: 2SIDER
US FAERS
135Disease ProgressionFAERS: 2US FAERS
136DiverticulitisFAERS: 2US FAERS
137ExophthalmosFAERS: 2US FAERS
138Incorrect dose administered by productFAERS: 2US FAERS
139Instillation site irritationFAERS: 2US FAERS
140Instillation site reactionFAERS: 2OFFSIDES
US FAERS
141KeratitisFAERS: 2SIDER
US FAERS
142Lip swellingFAERS: 2US FAERS
143Lipodystrophy acquiredFAERS: 2US FAERS
144Maternal exposure timing unspecifiedFAERS: 2US FAERS
145Melanoma recurrentFAERS: 2OFFSIDES
US FAERS
146MyalgiaFAERS: 2SIDER
US FAERS
147Ocular surface diseaseFAERS: 2US FAERS
148Oral painFAERS: 2US FAERS
149Peripheral swellingFAERS: 2US FAERS
150Post procedural complicationFAERS: 2US FAERS
151Product container seal issueFAERS: 2US FAERS
152SepsisFAERS: 2US FAERS
153StressFAERS: 2US FAERS
154Struck by lightningFAERS: 2US FAERS
155ThrombosisFAERS: 2US FAERS
156Toxicity to various agentsFAERS: 2US FAERS
157Urinary IncontinenceFAERS: 2SIDER
US FAERS
158Urinary tract infectionFAERS: 2SIDER
US FAERS
159Vital dye staining cornea presentFAERS: 2SIDER
US FAERS
160Wrong technique in product usage processFAERS: 2US FAERS
161AbasiaFAERS: 1US FAERS
162Abdominal PainFAERS: 1OFFSIDES
SIDER
US FAERS
163Accidental exposure to product by childFAERS: 1US FAERS
164AcneFAERS: 1US FAERS
165Acquired corneal dystrophyFAERS: 1US FAERS
166Adverse eventFAERS: 1US FAERS
167AmnesiaFAERS: 1US FAERS
168AneurysmFAERS: 1US FAERS
169AngerFAERS: 1US FAERS
170Angle Closure GlaucomaFAERS: 1OFFSIDES
US FAERS
171AnophthalmosFAERS: 1US FAERS
172AphoniaFAERS: 1US FAERS
173Application site irritationFAERS: 1OFFSIDES
US FAERS
174Atrial FlutterFAERS: 1OFFSIDES
US FAERS
175Back disorderFAERS: 1US FAERS
176Basal cell carcinomaFAERS: 1US FAERS
177BedriddenFAERS: 1US FAERS
178Benign Prostatic HyperplasiaFAERS: 1US FAERS
179Blood cholesterol abnormalFAERS: 1US FAERS
180Blood cholesterol increasedFAERS: 1US FAERS
181Blood glucose decreasedFAERS: 1US FAERS
182Blood potassium decreasedFAERS: 1US FAERS
183Blood pressure fluctuationFAERS: 1US FAERS
184Bone painFAERS: 1US FAERS
185Borderline glaucomaFAERS: 1US FAERS
186Bronchial irritationFAERS: 1US FAERS
187BronchitisFAERS: 1SIDER
US FAERS
188BronchospasmFAERS: 1US FAERS
189Cardiac FlutterFAERS: 1OFFSIDES
US FAERS
190Carpal Tunnel SyndromeFAERS: 1US FAERS
191Cataract operation complicationFAERS: 1US FAERS
192Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
193Coagulation factor VIII level decreasedFAERS: 1US FAERS
194ConstipationFAERS: 1SIDER
US FAERS
195Corneal OpacityFAERS: 1US FAERS
196Corneal dystrophyFAERS: 1US FAERS
197Corneal epithelium defectFAERS: 1OFFSIDES
SIDER
US FAERS
198Corneal graft rejectionFAERS: 1US FAERS
199Corneal lesionFAERS: 1US FAERS
200Coronary artery insufficiencyFAERS: 1US FAERS
201CryingFAERS: 1US FAERS
202CystFAERS: 1US FAERS
203Dacryostenosis acquiredFAERS: 1US FAERS
204DehydrationFAERS: 1OFFSIDES
US FAERS
205Depressed moodFAERS: 1US FAERS
206Device breakageFAERS: 1US FAERS
207Device malfunctionFAERS: 1US FAERS
208Device related infectionFAERS: 1OFFSIDES
US FAERS
209Drug ineffective for unapproved indicationFAERS: 1US FAERS
210Dry age-related macular degenerationFAERS: 1US FAERS
211Dry skinFAERS: 1OFFSIDES
US FAERS
212DysmorphismFAERS: 1US FAERS
213DysuriaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
214EczemaFAERS: 1US FAERS
215EmbolismFAERS: 1US FAERS
216Emotional distressFAERS: 1US FAERS
217Erythema MultiformeFAERS: 1US FAERS
218Excessive eye blinkingFAERS: 1US FAERS
219Expired drug administeredFAERS: 1US FAERS
220Eye RednessFAERS: 1US FAERS
221Eyelash hyperpigmentationFAERS: 1US FAERS
222Eyelid exfoliationFAERS: 1OFFSIDES
US FAERS
223Eyelid rashFAERS: 1US FAERS
224Feeling jitteryFAERS: 1US FAERS
225FibromyalgiaFAERS: 1US FAERS
226Forceps deliveryFAERS: 1US FAERS
227Gait inabilityFAERS: 1US FAERS
228Gastric ulcer helicobacterFAERS: 1US FAERS
229Gastrointestinal mucosal disorderFAERS: 1US FAERS
230Glaucoma surgeryFAERS: 1US FAERS
231GliosisFAERS: 1US FAERS
232Head discomfortFAERS: 1US FAERS
233HypokinesiaFAERS: 1US FAERS
234Inappropriate schedule of drug administrationFAERS: 1US FAERS
235Incorrect dose administered by deviceFAERS: 1US FAERS
236Incorrect product storageFAERS: 1US FAERS
237Incorrect storage of drugFAERS: 1US FAERS
238InfarctionFAERS: 1US FAERS
239Injection Site ReactionFAERS: 1US FAERS
240Instillation site painFAERS: 1US FAERS
241Intentional product misuseFAERS: 1US FAERS
242Intentional self-injuryFAERS: 1US FAERS
243IridocyclitisFAERS: 1SIDER
US FAERS
244Irritable Bowel SyndromeFAERS: 1US FAERS
245Keratoconjunctivitis SiccaFAERS: 1SIDER
US FAERS
246Laryngeal discomfortFAERS: 1US FAERS
247Larynx irritationFAERS: 1US FAERS
248Lid sulcus deepenedFAERS: 1SIDER
US FAERS
249LipoatrophyFAERS: 1US FAERS
250LymphadenopathyFAERS: 1US FAERS
251MeibomianitisFAERS: 1OFFSIDES
SIDER
US FAERS
252Migraine with AuraFAERS: 1US FAERS
253Mood swingsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
254MydriasisFAERS: 1SIDER
US FAERS
255Myocardial necrosis marker increasedFAERS: 1US FAERS
256Nasal discomfortFAERS: 1OFFSIDES
SIDER
US FAERS
257Nasal mucosal ulcerFAERS: 1US FAERS
258Nasal pruritusFAERS: 1US FAERS
259Neck PainFAERS: 1US FAERS
260NephrolithiasisFAERS: 1US FAERS
261NeuralgiaFAERS: 1US FAERS
262Ocular ToxicityFAERS: 1US FAERS
263Optic nerve cuppingFAERS: 1US FAERS
264OsteoporosisFAERS: 1OFFSIDES
US FAERS
265OverdoseFAERS: 1US FAERS
266PallorFAERS: 1US FAERS
267Pancreatic NeoplasmFAERS: 1US FAERS
268PapuleFAERS: 1US FAERS
269Paranasal sinus discomfortFAERS: 1US FAERS
270Pelvic PainFAERS: 1US FAERS
271Periorbital disorderFAERS: 1OFFSIDES
US FAERS
272PharyngitisFAERS: 1SIDER
US FAERS
273Post-Traumatic Stress DisorderFAERS: 1US FAERS
274Post-traumatic neck syndromeFAERS: 1US FAERS
275Posterior capsule opacificationFAERS: 1US FAERS
276Posterior capsule ruptureFAERS: 1US FAERS
277PregnancyFAERS: 1US FAERS
278Prescribed overdoseFAERS: 1US FAERS
279PresyncopeFAERS: 1US FAERS
280Product design issueFAERS: 1US FAERS
281Product dispensing errorFAERS: 1US FAERS
282Product dispensing issueFAERS: 1US FAERS
283Product dosage form issueFAERS: 1US FAERS
284Product expiration date issueFAERS: 1US FAERS
285Product outer packaging issueFAERS: 1US FAERS
286Product physical consistency issueFAERS: 1US FAERS
287Product prescribing errorFAERS: 1US FAERS
288Product substitution issueFAERS: 1
Canada Vigilance: 4
Canada Vigilance
US FAERS
289Product taste abnormalFAERS: 1US FAERS
290Prostate examination abnormalFAERS: 1US FAERS
291Pulmonary congestionFAERS: 1US FAERS
292Rash erythematousFAERS: 1US FAERS
293Reaction to excipientFAERS: 1US FAERS
294Reflux laryngitisFAERS: 1US FAERS
295Renal cystFAERS: 1US FAERS
296Renal painFAERS: 1US FAERS
297Respiratory FailureFAERS: 1US FAERS
298RestlessnessFAERS: 1US FAERS
299Retinal Artery OcclusionFAERS: 1US FAERS
300Retinal DegenerationFAERS: 1US FAERS
301Retinal scarFAERS: 1US FAERS
302Rheumatoid ArthritisFAERS: 1US FAERS
303Rotator cuff syndromeFAERS: 1US FAERS
304Sjogren's SyndromeFAERS: 1US FAERS
305Skin WrinklingFAERS: 1US FAERS
306SneezingFAERS: 1US FAERS
307StarvationFAERS: 1US FAERS
308StenosisFAERS: 1US FAERS
309SwellingFAERS: 1US FAERS
310Temporal ArteritisFAERS: 1US FAERS
311Tendon discomfortFAERS: 1US FAERS
312TensionFAERS: 1US FAERS
313Therapeutic product contaminationFAERS: 1US FAERS
314TracheitisFAERS: 1US FAERS
315Unevaluable eventFAERS: 1US FAERS
316Upper respiratory tract congestionFAERS: 1US FAERS
317Upper-airway cough syndromeFAERS: 1US FAERS
318Urinary RetentionFAERS: 1US FAERS
319Urine flow decreasedFAERS: 1US FAERS
320VIIth nerve paralysisFAERS: 1OFFSIDES
US FAERS
321Vascular stent restenosisFAERS: 1US FAERS
322Vein collapseFAERS: 1US FAERS
323Violence-related symptomFAERS: 1US FAERS
324Visual disturbanceFAERS: 1US FAERS
325Vitreous floatersFAERS: 1US FAERS
326VitritisFAERS: 1US FAERS
327Walking aid userFAERS: 1US FAERS
328WheezingFAERS: 1US FAERS
329nervous system disorderFAERS: 1SIDER
US FAERS
330treatment failureFAERS: 1US FAERS
331Abdominal rigidityOFFSIDES
332Abnormal visionOFFSIDES
SIDER
333Accidental overdoseOFFSIDES
334Acquired diaphragmatic eventrationOFFSIDES
335Acute prerenal failureOFFSIDES
336Acute respiratory failureOFFSIDES
337AdenocarcinomaOFFSIDES
338AmputationOFFSIDES
339AnisocoriaOFFSIDES
340Anterior chamber flareSIDER
341Anterior chamber pigmentationSIDER
342AppendectomyOFFSIDES
343Application site exfoliationOFFSIDES
344Application site scabOFFSIDES
345Arteriosclerosis ObliteransOFFSIDES
346Aspiration PneumoniaOFFSIDES
347Asthma aggravatedSIDER
348AstigmatismOFFSIDES
349Asymptomatic bacteriuriaOFFSIDES
350AtelectasisOFFSIDES
351Atrial tachycardiaOFFSIDES
352AuraOFFSIDES
353BelligerenceOFFSIDES
354Bifascicular blockOFFSIDES
355BlepharoptosisOFFSIDES
356Blood GlucoseOFFSIDES
357Blood creatine increasedOFFSIDES
358Blood creatinine increasedOFFSIDES
359Blood immunoglobulin A decreasedOFFSIDES
360Blood immunoglobulin G decreasedOFFSIDES
361Blood sodiumOFFSIDES
362Blood triglycerides increasedOFFSIDES
363Blood urea increasedOFFSIDES
364Blurred visionOFFSIDES
365Brain ConcussionOFFSIDES
366Brain natriuretic peptide increasedOFFSIDES
367Bronchial ObstructionOFFSIDES
368BronchiectasisOFFSIDES
369BulimiaOFFSIDES
370Cardioactive drug level increasedOFFSIDES
371Carotid artery occlusionOFFSIDES
372CellulitisOFFSIDES
373Cerebral ArteriosclerosisOFFSIDES
374Chronic Obstructive Airway DiseaseOFFSIDES
375Chronic sinusitisOFFSIDES
376Congenital tricuspid valve incompetenceOFFSIDES
377Conjunctival depositOFFSIDES
378Conjunctival irritationCanada Vigilance: 1Canada Vigilance
379Corneal UlcerOFFSIDES
380Corneal abscessOFFSIDES
381Corneal erosionOFFSIDES
SIDER
382Corneal pigmentationSIDER
383Cutis LaxaOFFSIDES
384DebridementOFFSIDES
385DermatitisSIDER
386Diabetic RetinopathyOFFSIDES
387DiarrheaOFFSIDES
388Disease complicationOFFSIDES
389DisorientationCanada Vigilance: 1Canada Vigilance
390Drug toxicityOFFSIDES
391DyspepsiaSIDER
392Ear and labyrinth disordersSIDER
393Economic problemOFFSIDES
394EctropionSIDER
395Electromechanical dissociationOFFSIDES
396Endodontic procedureOFFSIDES
397EndophthalmitisSIDER
398EpiduritisOFFSIDES
399Eyelid DiseasesOFFSIDES
400Eyelid irritationOFFSIDES
SIDER
401Eyelid painSIDER
402Feeling ColdOFFSIDES
403Feeling of body temperature changeOFFSIDES
404FolliculitisOFFSIDES
405GastrectomyOFFSIDES
406Gastrointestinal PainSIDER
407Gastrointestinal stoma complicationOFFSIDES
408GoutOFFSIDES
409GranulocytosisOFFSIDES
410HemiparesisOFFSIDES
411HemiplegiaOFFSIDES
412Hemisensory NeglectOFFSIDES
413Hepatitis B antibody positiveOFFSIDES
414HostilityOFFSIDES
415Hyperemia15321024CTD
416HyperpigmentationOFFSIDES
417HypertrichosisSIDER
418HypophagiaOFFSIDES
419HysterectomyOFFSIDES
420Implantable defibrillator insertionOFFSIDES
421InfectionSIDER
422InfestationSIDER
423InflammationSIDER
424Instillation site complicationCanada Vigilance: 1Canada Vigilance
425Intraocular inflammationOFFSIDES
426Intraocular pressure testOFFSIDES
427Kidney NeoplasmOFFSIDES
428LacrimationSIDER
429Left Ventricular HypertrophyOFFSIDES
430Left atrial dilatationOFFSIDES
431LethargyOFFSIDES
432Life expectancy shortenedOFFSIDES
433Medical device complicationOFFSIDES
434MeningitisCanada Vigilance: 1Canada Vigilance
435Mental status changesOFFSIDES
436Metastases to the respiratory systemOFFSIDES
437MetrorrhagiaSIDER
438MonocytosisOFFSIDES
439Muscle WeaknessOFFSIDES
440Musculoskeletal PainOFFSIDES
SIDER
441Musculoskeletal discomfortSIDER
442Mycotic corneal ulcerOFFSIDES
443Myeloid MetaplasiaOFFSIDES
444MyopiaOFFSIDES
445NystagmusOFFSIDES
446Ocular Hypotension15321024CTD
447Oroantral FistulaOFFSIDES
448PanophthalmitisSIDER
449Peptic UlcerSIDER
450Peptic ulcer reactivatedSIDER
451Physical disabilityOFFSIDES
452PingueculaOFFSIDES
453PolyneuropathyOFFSIDES
454PresbyopiaOFFSIDES
455Productive CoughOFFSIDES
456Pulmonary HypertensionOFFSIDES
457Reaction to preservativesOFFSIDES
458Renal massOFFSIDES
459Renal vein occlusionOFFSIDES
460Retinal Vein OcclusionOFFSIDES
461Retinal pigment epitheliopathyOFFSIDES
462Retinal pigmentationSIDER
463RetinitisOFFSIDES
464RhinalgiaOFFSIDES
465RhinitisSIDER
466ScabSIDER
467ScotomaOFFSIDES
SIDER
468Secretion dischargeOFFSIDES
469Shoulder PainSIDER
470Sick Sinus SyndromeOFFSIDES
471Sinus bradycardiaOFFSIDES
472Splenic abscessOFFSIDES
473SpondylitisOFFSIDES
474Squamous cell carcinoma of skinOFFSIDES
475Stem cell transplantOFFSIDES
476Stevens-Johnson SyndromeOFFSIDES
477Subconjunctival hemorrhageSIDER
478Sunken eyesSIDER
479Supraventricular tachycardiaOFFSIDES
480TenosynovitisOFFSIDES
481Thoracic cavity drainageOFFSIDES
482Tooth ExtractionOFFSIDES
483Tooth InfectionOFFSIDES
484Tooth LossOFFSIDES
485TrabeculectomyOFFSIDES
486Transfusion ReactionOFFSIDES
487Troponin increasedOFFSIDES
488Ultrasound pelvisOFFSIDES
489Unresponsive to stimuliOFFSIDES
490Urine cytology abnormalOFFSIDES
491Vascular ruptureOFFSIDES
492Ventricular FibrillationOFFSIDES
493Vitreous DetachmentSIDER
494Wound infection staphylococcalOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.